Guardant Health (GH) PT Raised to $200 at RBC Capital
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $179.38 -2.03%
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
RBC Capital analyst Dan Leonard raised the price target on Guardant Health (NASDAQ: GH) to $200.00 (from $185.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Piper Sandler on Guardant Health (GH): 'Investors can take this opportunity to add to their position'
- Polaris Industries (PII) PT Lowered to $61 at UBS, Neutral Rating Maintained
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
